Alba Noguerido
Overview
Explore the profile of Alba Noguerido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elez E, Mulet-Margalef N, Sanso M, Ruiz-Pace F, Mancuso F, Comas R, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613564
The search for immunotherapy biomarkers in Microsatellite Instability High/Deficient Mismatch Repair system (MSI-H/dMMR) metastatic colorectal cancer (mCRC) is an unmet need. Sixteen patients with mCRC and MSI-H/dMMR (determined by either...
2.
Elez E, Chianese C, Sanz-Garcia E, Martinelli E, Noguerido A, Mancuso F, et al.
Mol Oncol
. 2019 Jul;
13(9):1827-1835.
PMID: 31322322
Despite major advances in the treatment of metastatic colorectal cancer (mCRC), the survival rate remains very poor. This study aims at exploring the prognostic value of RAS-mutant allele fraction (MAF)...
3.
Matos I, Noguerido A, Ros J, Mulet N, Argiles G, Elez E, et al.
Expert Opin Investig Drugs
. 2019 Mar;
28(5):463-471.
PMID: 30905200
Introduction: The addition of monoclonal antibody (mAb) epidermal growth factor receptor (EGFR) inhibitors to classic chemotherapy doublet backbones has improved survival of metastatic colorectal cancer (mCRC). However, the role of...
4.
Noguerido A, Mulet-Margalef N, Matos I, Ros J, Argiles G, Elez E, et al.
Expert Opin Drug Saf
. 2018 Aug;
17(9):945-951.
PMID: 30073902
Ramucirumab, a human monoclonal antibody against vascular endothelial growth factor receptor 2 (VEGFR-2), is an antiangiogenic therapy that has been approved in combination with FOLFIRI in second-line treatment of metastatic...